Inotiv Inc

-0.83 (-3.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)320.14M
Current PEN/A
Forward PE N/A
2yr Forward PE 32.61
See more stats
Estimates Current Quarter
Revenue$21.11 Million
Adjusted EPS-$0.01
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Inotiv Inc Stock, NASDAQ:NOTV

2701 Kent Avenue, 2701 Kent Avenue, West Lafayette, Indiana 47906-1382
United States of America
Phone: +1.765.463.4527
Number of Employees: 421


Inotiv, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.